Literature DB >> 8528067

Synthesis, activity, and preliminary structure of the fourth EGF-like domain of thrombomodulin.

D P Meininger1, M J Hunter, E A Komives.   

Abstract

The fourth EGF-like domain of thrombomodulin (TM4), residues E346-F389 in the TM sequence, has been synthesized. Refolding of the synthetic product under redox conditions gave a single major product. The disulfide bonding pattern of the folded, oxidized domain was (1-3, 2-4, 5-6), which is the same as that found in EGF protein. TM4 was tested for TM anticoagulant activity because deletion and substitution mutagenesis experiments have shown that the fourth EGF-like domain of TM is essential for TM cofactor activity. TM4 showed no TM-like activity in two assay systems, both for inhibition of fibrin clot formation, and for cofactor activity in thrombin activation of protein C. A preliminary structure of TM4 was determined by 2D 1H NMR from 519 NOE-derived distance constraints. Distance geometry calculations yielded a single convergent structure. The structure resembles the structure of EGF and other known EGF-like domains but has some key differences. The central two-stranded beta-sheet is conserved despite the differences in the number of amino acids in the loops. The C-terminal loop formed by the disulfide bond between C372 and C386 in TM4 is five amino acids longer than the analogous loop between C33 and C42 of EGF protein. This loop appears to have a different fold in TM4 than in EGF protein. The loop forms the two outside strands of a broken, irregular tri-stranded beta-sheet, and amino acids H384-F389 lie between the two strands forming the middle strand of the sheet. Thus, although the C-terminus of EGF protein forms one of the outside strands of a tri-stranded antiparallel sheet, the C-terminus of TM4 forms the inside strand of an irregular tri-stranded parallel-anti-parallel sheet. The residues D349, E357, and E374, which were shown to be critical for cofactor activity by alanine scanning mutagenesis, all lie in a patch near the C-terminal loop, and are solvent accessible. The other critical residues, Y358 and F376, are largely buried and appear to play essential structural rather than functional roles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528067      PMCID: PMC2143218          DOI: 10.1002/pro.5560040904

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  31 in total

1.  Conformational stability of a thrombin-binding peptide derived from the hirudin C-terminus.

Authors:  F Ni; D R Ripoll; E O Purisima
Journal:  Biochemistry       Date:  1992-03-10       Impact factor: 3.162

2.  The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha.

Authors:  M Baron; D G Norman; T S Harvey; P A Handford; M Mayhew; A G Tse; G G Brownlee; I D Campbell
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

3.  On the multiple simultaneous superposition of molecular structures by rigid body transformations.

Authors:  R Diamond
Journal:  Protein Sci       Date:  1992-10       Impact factor: 6.725

4.  Epidermal growth factor. Location of disulfide bonds.

Authors:  C R Savage; J H Hash; S Cohen
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

5.  Sequences required for thrombomodulin cofactor activity within the fourth epidermal growth factor-like domain of human thrombomodulin.

Authors:  S R Lentz; Y Chen; J E Sadler
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

6.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins.

Authors:  D Marion; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1983-06-29       Impact factor: 3.575

7.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

Authors:  A Kumar; R R Ernst; K Wüthrich
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

8.  How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X.

Authors:  M Selander-Sunnerhagen; M Ullner; E Persson; O Teleman; J Stenflo; T Drakenberg
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

9.  Solution structure of human type-alpha transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints.

Authors:  F J Moy; Y C Li; P Rauenbuehler; M E Winkler; H A Scheraga; G T Montelione
Journal:  Biochemistry       Date:  1993-07-27       Impact factor: 3.162

10.  Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity.

Authors:  M Nagashima; E Lundh; J C Leonard; J Morser; J F Parkinson
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  4 in total

1.  Orientation and helical conformation of a tissue-specific hunter-killer peptide in micelles.

Authors:  Leigh A Plesniak; Jonathan I Parducho; Angie Ziebart; Bernhard H Geierstanger; Jennifer A Whiles; Guiseppe Melacini; Patricia A Jennings
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

2.  The fifth epidermal growth factor-like domain of thrombomodulin does not have an epidermal growth factor-like disulfide bonding pattern.

Authors:  C E White; M J Hunter; D P Meininger; S Garrod; E A Komives
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

3.  Acidic phospholipid bicelles: a versatile model membrane system.

Authors:  J Struppe; J A Whiles; R R Vold
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

4.  Production of large quantities of isotopically labeled protein in Pichia pastoris by fermentation.

Authors:  M J Wood; E A Komives
Journal:  J Biomol NMR       Date:  1999-02       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.